Form 4 for QNCX Quince Therapeutics, Inc.
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-12 · accession 0001209191-21-064346 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-11-12 | 2021-11-12 | QNCX | Dominy Stephen S. | CSO, Dir | P - Purchase | $14.40 | +763 | 1.22M | +0.1% | +$11.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-12 | P | A | 763 | $14.40 | 1,217,086 | I By the Dominy Family Trust 2016 | — | — | (F1) Stephen S. Dominy is a trustee of the Dominy Family Trust 2016, and shares voting and dispositive power with one other trustee with respect to the shares held of record by the Dominy Family Trust 2016. |